. . . . . . . . . . . . . . "a(CHEBI:rosiglitazone) -> kin(p(HGNC:MAPK14))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Besides binding to specific elements in the ucp-1 enhancer, rosiglitazone has extragenic effects activating p38 mitogen-activated protein kinase (MAPK), a necessary signal for UCP-1 induction (Teruel et al. 2003)." . . "Selventa" . . . . "2014-07-03T14:30:33.513+02:00"^^ . . .